Antegrade Autologous Blood Reinfusion After CPB

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorKocaeli City Hospital

About this trial

This prospective observational study aims to evaluate the effect of antegrade pump blood reinfusion using the crystalloid "chase" technique on postoperative transfusion requirements in adult patients undergoing cardiac surgery with cardiopulmonary bypass. At the end of cardiopulmonary bypass, blood remaining within the cardiopulmonary bypass circuit is reinfused antegradely through the arterial line using a crystalloid chase, without collection or storage. Blood remaining within the bypass circuit after surgery represents a valuable source of autologous blood, and its reinfusion may contribute to perioperative blood conservation strategies. Patients receiving antegrade pump blood reinfusion via the chase technique will be compared with those managed without reinfusion, without any intervention by the investigators. The primary outcome is postoperative blood transfusion requirement.

Eligibility criteria

Qualifiers

Age 18 to 80 years

Patients undergoing elective, isolated coronary artery bypass grafting surgery using cardiopulmonary bypass (on-pump).

Disqualifiers

Emergency or Redo cardiac surgery

Concomitant cardiac procedures (e.g., valve repair/replacement or aortic surgery).

Planned or intraoperative conversion to off-pump coronary artery bypass grafting

Preoperative hematocrit <30% or known inherited/acquired bleeding disorders.

Trial design

Treatments tested in this trial

  • Antegrade Pump Blood Reinfusion
  • No Anterograde Pump Blood Reinfusion

Treatment groups

130 Participants
are divided into 2 treatment groups

Sponsors and collaborators